Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Millions, unless otherwise specified
 12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Operating activities:      
Consolidated net income $ 241.7 $ 274.8 $ 240.5
Adjustments to reconcile consolidated net income to net cash provided by operating activities:      
Loss (gain) on divestitures 26.3 (27.1)  
Depreciation and amortization 164.9 167.8 158.8
Stock-based compensation expense 24.4 21.8 19.6
Excess tax benefits from stock-based compensation plans (1.2) (3.5) (1.3)
Deferred income taxes 3.6 0.1 14.7
Changes in assets and liabilities, excluding effects of acquisitions:      
Accounts receivable, net (26.6) (3.6) 12.8
Prepaid expenses and other current assets 2.4 6.1 (1.4)
Other assets 15.0 (1.4) (6.9)
Current liabilities, excluding debt 1.3 (32.4) 4.2
Other long-term liabilities, excluding debt (43.1) (50.0) (22.6)
Cash provided by operating activities 408.7 352.6 418.4
Investing activities:      
Capital expenditures (75.0) (99.8) (70.7)
Acquisitions, net of cash acquired (127.4) (82.6) (196.0)
Proceeds received from divestitures 2.5 181.7  
Investment in unconsolidated affiliates, net (4.2) 1.7 (3.4)
Cash provided by (used in) investing activities (204.1) 1.0 (270.1)
Financing activities:      
Net short-term (repayments) borrowings 24.4 (134.0) 101.8
Net (repayments) borrowings under long-term revolving credit facilities   (5.0) (415.2)
Payments on long-term debt (16.7) (20.8) (31.8)
Proceeds from issuance of long-term debt     274.4
Treasury stock purchases (142.3) (167.5) (23.8)
Dividends paid to Equifax shareholders (78.1) (35.2) (20.2)
Dividends paid to noncontrolling interests (5.6) (5.1) (4.0)
Proceeds from exercise of stock options 23.7 29.3 10.2
Excess tax benefits from stock-based compensation plans 1.2 3.5 1.3
Other (2.5) (0.5) (1.0)
Cash used in financing activities (195.9) (335.3) (108.3)
Effect of foreign currency exchange rates on cash and cash equivalents (0.4) (2.0) 4.9
Increase in cash and cash equivalents 8.3 16.3 44.9
Cash and cash equivalents, beginning of period 119.4 103.1 58.2
Cash and cash equivalents, end of period $ 127.7 $ 119.4 $ 103.1